Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients

Research output: Contribution to journalJournal articleResearchpeer-review

  • Samuel Z Goldhaber
  • Alain Leizorovicz
  • Ajay K Kakkar
  • Sylvia K Haas
  • Geno Merli
  • Robert M Knabb
  • Jeffrey I Weitz
  • ADOPT Trial Investigators
  • Torp-Pedersen, Christian Tobias
The efficacy and safety of prolonging prophylaxis for venous thromboembolism in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that extended prophylaxis with apixaban would be safe and more effective than short-term prophylaxis with enoxaparin.
Original languageEnglish
JournalNew England Journal of Medicine
Volume365
Issue number23
Pages (from-to)2167-77
Number of pages11
ISSN0028-4793
DOIs
Publication statusPublished - 8 Dec 2011

ID: 48592308